The latest addition to Blueprint: CaAKG. [Link on comment].

In this video, Bryan Johnson explains his two primary objectives—slowing the rate of aging and reversing existing biological damage—and announces the addition of calcium alpha‑ketoglutarate (CaAKG) to his anti‑aging Blueprint regimen. He references a mouse study that used a frailty index (assessing tremors, tumors, fur loss, etc.) and reported a substantial 20‑year human‑equivalent improvement, effectively shifting an 80‑year‑old physiological profile to that of a 60‑year‑old. Johnson judges the study results compelling enough to warrant evaluation, notes that CaAKG meets his safety criteria, and outlines that he will begin taking it immediately while continuing his standard measurement protocols. He provides links in the video comments for purchasing CaAKG and commits to sharing future data on its effects.










